Tumour Necrosis Factor Modulation for Treatment of Alzheimer's Disease: Rationale and Current Evidence

ISSN： 1172-7047

Source： CNS Drugs, Vol.23, Iss.9, 2009-09, pp. : 713-725

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intravenous Immunoglobulins as a Treatment for Alzheimer's Disease: Rationale and Current Evidence

By Dodel Richard

Drugs, Vol. 70, Iss. 5, 2010-03 ,pp. : 513-528

Adis International

Access to resources Recommend Favorite

The Future Role of Anti-Tumour Necrosis Factor- Products in the Treatment of Crohn's Disease

By van Hogezand R.A. Verspaget H.W.

Drugs, Vol. 56, Iss. 3, 1998-09 ,pp. : 299-305

Adis International

Access to resources Recommend Favorite

Anti-Tumour Necrosis Factor Therapy for Ulcerative Colitis: Evidence to Date

By Thukral Chandrashekhar Cheifetz Adam Peppercorn Mark A.

Drugs, Vol. 66, Iss. 16, 2006-01 ,pp. : 2059-2065

Adis International

Access to resources Recommend Favorite

Tumour necrosis factor antagonists

By Chantry D.

Expert Opinion on Emerging Drugs, Vol. 4, Iss. 1, 1999-01 ,pp. : 5-13

Informa Healthcare

Access to resources Recommend Favorite

Leukaemic Transformation in Patients with Haematological Disease Receiving Tumour Necrosis Factor Inhibitors

By Ferrer-Marín Francisca > Vicente Vicente

Clinical Drug Investigation, Vol. 32, Iss. 6, 2012-06 ,pp. : 423-426

Adis International

Access to resources Recommend Favorite